The Cold Fluids Study

PHASE4CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 24, 2022

Primary Completion Date

December 3, 2022

Study Completion Date

December 3, 2022

Conditions
Hemodynamic Instability
Interventions
DRUG

Ringer's Lactate

"On the first trial day healthy volunteers are randomized to receive 30 ml/kg of Ringer's lactate either cold (15°C, 59°F), or at body temperature (37°C, 98.6°F) during a 30-minute interval. After a minimum washout period of 24 hours, subjects are switched to receive infusion at the other aforementioned temperatures."

Trial Locations (1)

5000

Odense University Hospital, Odense

All Listed Sponsors
collaborator

Odense University Hospital

OTHER

collaborator

University of Southern Denmark

OTHER

collaborator

Simon Fougner Hartmanns Family Foundation

UNKNOWN

collaborator

Department of Clinical Biochemistry, Vejle Hospital

UNKNOWN

lead

Esbjerg Hospital - University Hospital of Southern Denmark

OTHER